18.12.2022 | Tracker

Top 50 Pharma Tracker: HCPs actively discussed issues concerning mRNA and bivalent COVID-19 vaccines

By Francesca Gan

Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter

November RankOctober RankCompany
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer5,104246
214Lilly2,471019
32Moderna2,13200
43Johnson & Johnson1,261243
54AstraZeneca752244
65GSK651273
77Roche380033
810Novo Nordisk342019
920AbbVie33953
1012Sanofi328131
119Novartis291218
1216Takeda28424
1311Bayer274040
146Abbott22906
1517Boehringer Ingelheim19208
168Merck & Co189617
1719Eisai17206
1821Biogen12701
1915Amgen108219
2013Gilead Sciences106740
2118Fresenius8206
2223Otsuka7801
2322BMS7750
2429Organon7000
2532Merck KGaA62020
2626Servier5808
2731Ipsen5703
2842Vertex5300
2925Teva52023
3030Daiichi Sankyo5201
3135Viatris5200
3238Astellas4800
3324Stada3800
3434CSL3601
3527Regeneron3001
3628UCB29010
3736Menarini2703
3833Bausch2300
3939Alexion2101
4037Grifols1800
4145Kyowa Kirin900
4241Jazz Pharmaceuticals600
4240Aurobindo600
4442CSPC500
4544Sun400
5050Jiangsu Hengrui000
5050Endo000
5050Sino000
5050Shanghai000
5050Sumitomo Dainippon000

The latest insights from HCPs mentioning the Top 50 Pharmaceutical Companies

The five pharmaceutical companies that were mentioned the most by healthcare professionals (HCPs) on Twitter in November 2022 were Pfizer, Lilly, Moderna, Johnson & Johnson and AstraZeneca. Notably, Lilly rose from the 14th most mentioned pharmaceutical company online in October 2022 to 2nd in November.

CREATION.co identified 14,537 HCP mentions of pharmaceutical companies online in November 2022, a 22% decrease from the previous month.

The primary factor of Lilly’s rise in ranking of most mentioned pharmaceutical companies in November 2022 was discussions around the cost of insulin, with HCPs expressing frustration and anger at the increase of the price of insulin since its discovery, with 387 HCPs sharing a tweet by Bernie Sanders expressing that sentiment.

218 HCPs also shared a tweet highlighting the financial consequences of a Twitter Blue post in which Eli Lilly’s official account was impersonated: 

The top shared links by HCPs discussed:

  1. An article from Stat news about the new bivalent COVID-19 vaccine and its efficacy in protecting against new Omicron variants.
  2. A press release by Pfizer announcing phase 3 trial data for their bivalent RSV vaccine.
  3. An article by the Washington Post about the fake tweet imitating Eli Lilly.

HCPs also shared their excitement about the efficacy of Pfizer’s new bivalent RSV vaccine, with 82 HCPs sharing the following tweet:

Additionally, Gilead Sciences had a high number of account mentions, with 74 mentions of their official Twitter account. This was primarily due to work with the Gilead scholarships:

CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

 

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

 

Methodology notes:

    • In November 2022, CREATION Pinpoint® identified 14,537 healthcare professional authored tweets from 6,384 individual HCPs mentioning a Top 50 Pharmaceutical company (according to revenue). 
    • Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 November and 30 November 2022.
  • Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
  • In some cases, a tweet may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.

Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In November 2022, 110 of these posts mentioned Janssen.

Click here to view the latest article 

View all articles >

Meet the Author

Francesca Gan

Fran analyses the unprompted online conversations of healthcare professionals to produce actionable insights for clients. Her background in legal research provides a solid foundation in critical thinking and enables a well rounded approach to her data research.

Fran has a keen interest in netball and is a big follower of the New Zealand domestic netball league. She is also a lover of board games and card games, especially ones that involve shouting!

Suggested next


10.06.2021 | Article

The role of Digital Opinion Leaders is more important than ever

The role of Digital Opinion Leaders is more important than ever

By Daniel Ghinn

29.03.2021 | Article

The difference between DOLs and KOLs and why it matters to pharma

Key Opinion Leaders vs Digital Opinion Leaders

By Katie Kennedy

View all articles >